A possible solution to enhance existing drug and gene therapies is to develop hybrid nanocarriers capable of delivering therapeutic agents in a controlled and targeted manner. This goal can be achieved by designing nanohybrid systems, which combine organic or inorganic nanomaterials with biomacromolecules into a single composite. The unique combination of properties along with their facile fabrication enables the design of smart carriers for both drug and gene delivery. These hybrids can be further modified with cell targeting motifs to enhance their biological interactivity. In this Talents and Trends article, an overview of emerging nanohybrid-based technologies will be provided to highlight their potential use as innovative platforms for improved cancer therapies and new strategies in regenerative medicine. The clinical relevance of these systems will be reviewed to define the current challenges which still need to be addressed to allow these therapies to move from bench to bedside.
Keyphrases
- cancer therapy
- reduced graphene oxide
- drug delivery
- drug release
- papillary thyroid
- gold nanoparticles
- single cell
- genome wide
- stem cells
- adverse drug
- squamous cell
- water soluble
- climate change
- gene expression
- quantum dots
- mesenchymal stem cells
- human health
- dna methylation
- transcription factor
- lymph node metastasis
- solid state